Transcat (TRNS) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$348.4M

Revenue (quarter)

$92.9M

Revenue growth (year over year)

+21.62%

Gross profit (trailing twelve months)

$113.2M

Gross margin

32.50%

Net income (trailing twelve months)

$3.4M

Net income (quarter)

$1.3M

Net income growth (year over year)

−59.18%

Net margin

0.99%

Return on equity

1.16%

EPS (trailing twelve months)

—

Book value per share

$24.75

P/E (trailing twelve months)

222.42

Price to book

2.53

Debt to assets

22.27%

Payout ratio

—

Dividend yield

—

Company profile

Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.

• Is Transcat (TRNS) profitable?

  Yes. Transcat earned $3.4M in net income over the trailing twelve months, a net margin of 0.99%.

• How much revenue does Transcat (TRNS) make?

  Transcat generated $348.4M in revenue over the trailing twelve months, up 21.62% year over year.

• What is TRNS's P/E ratio?

  Transcat trades at 222.4 times trailing twelve-month earnings, on an EPS of $0.00.

• How do I buy stock in Transcat (TRNS)?

  TRNS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.